HUM Stock Humana Inc.
STRONG BUY US · NYSEMedicare Advantage reset expectations and upgraded analyst sentiment could drive a valuation rebound.
Future value: $465.13 (+11.48%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Cantor upgraded to Overweight with a sharply higher target.
- ▸Above 50-day MA (+4.74%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (86.6% of range) — strength
Is HUM a buy right now?
Trend: HUM is trading above the 50-day average (+4.74%), RSI 45 — neutral momentum, with a 3-month return of +7.33%.
Valuation & quality: Humana Inc. trades on a trailing P/E of 39.4, forward P/E 24.4, PEG 1.16, price-to-book 2.61; fundamentals show net margin 0.9%, return on equity 6.9%, revenue growth 26.2% year on year.
Analyst consensus: 24 analysts have a mean 12-month price target of $465.13 (+11.5% vs the last close; range $280.00 – $596.00), consensus rating “buy”.
Income: trailing dividend yield 0.84%.
Our screen: STRONG BUY (score 5) — Medicare Advantage reset expectations and upgraded analyst sentiment could drive a valuation rebound.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -9.00% | +36.40% | +29.20% | +30.10% | -8.40% | +5.30% | -0.40% | +9.30% |
Fundamentals
Analyst price target
Technical signals
About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.
Sector: Healthcare · Industry: Healthcare Plans · United States · 67,060 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.